Note: Ingredients listed on restricted chemical lists
EC/CAS
118134-30-8
Name of the chemical
Spiroxamin (ISO); 8-tert-Butyl-1,4-dioxaspiro[4,5]dec-2-ylmethylethylpropylamin (2017/776)
Concentration
30.61
General Information
Version
1.0/UK
Revision date
2025-11-17
Product name
ASPIRE
1.2.1 Relevant identified uses
Fungicide
Icons in SDS
Company Information
company name
Sharda Cropchem Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
regn@shardaintl.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H302+H332, H315, H319, H332, H335, H361d, H373, H400, H410
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No additional information available
Hazard pictograms
GHS07 GHS08 GHS09
Signal word
Warning
Hazard statements
H302+H332 - Harmful if swallowed or if inhaled. H315 - Causes skin irritation. H319 - Causes serious eye irritation. H335 - May cause respiratory irritation. H361d - Suspected of damaging the unborn child. H373 - May cause damage to organs through prolonged or repeated exposure. H410 - Very toxic to aquatic life with long lasting effects.
Precautionary statements
P280 - Wear protective gloves/ protective clothing/ eye protection/ face protection. P312- Call a POISON CENTER/doctor/physician if you feel unwell. P410 - Protect from sunlight. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
Supplemental label elements
EUH208 - Contains 2-[2-(1-chlorocyclopropyl)-2-hydroxy-3-phenylpropyl]-2,4-dihydro-3H- 1,2,4-triazole-3-thione, Spiroxamine. May produce an allergic reaction. EUH401 - To avoid risks to human health and the environment, comply with the instructions for use.
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity (oral), Category 4 H302 Acute toxicity (inhalation), Category 4 H332 Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 2 H319 Reproductive toxicity, Category 2 H361d Specific target organ toxicity – Single exposure, Category 3, Respiratory tract irritation H335 Specific target organ toxicity – Repeated exposure, Category 2 H373 Hazardous to the aquatic environment – Acute Hazard, Category 1 H400 Hazardous to the aquatic environment – Chronic Hazard, Category 1 H410 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available